etalpha 0.25 mikrog
cheplapharm arzneimittel gmbh - alfakalsidol - kapsel, myk - 0.25 mikrog
etalpha 0.5 mikrog
cheplapharm arzneimittel gmbh - alfakalsidol - kapsel, myk - 0.5 mikrog
vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidemiene - lipid modifiserende midler - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
berocca
bayer as - askorbinsyre / monofosfotiamin / riboflavinnatriumfosfathydrat / nikotinamid / kalsiumpantotenat / pyridoksinhydroklorid / cyanokobalamin / folsyre / biotin / kalsiumkarbonat / magnesiumsubkarbonat, tungt / magnesiumsulfatdihydrat / sinksitrattrihydrat - brusetablett - 500 mg / 18.54 mg / 15 mg / 50 mg / 25 mg / 10 mg / 0.01 mg / 0.4 mg / 0.15 mg / 244 mg / 195 mg / 328 mg / 32 mg
bencium 500 mg / 800 iu
consilient health limited - kalsiumkarbonat / kolekalsiferol - tyggetablett med appelsinsmak - 500 mg / 800 iu
bencium 500 mg / 2000 iu
consilient health ltd. - kalsiumkarbonat / kolekalsiferol - tyggetablett med appelsinsmak - 500 mg / 2000 iu
calcipotriol/betamethasone sandoz 50 mikrog/ g / 0.5 mg/ g
sandoz - københavn - kalsipotriolmonohydrat / betametasondipropionat - salve - 50 mikrog/ g / 0.5 mg/ g
koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - antineoplastiske midler - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
fucidin-hydrocortison 20 mg/ g / 10 mg/ g
leo pharma - fusidinsyrehemihydrat / hydrokortisonacetat - krem - 20 mg/ g / 10 mg/ g
smoflipid
fresenius kabi norge as - halden - soyaolje, renset / triglyserider av middels kjedelengde / olivenolje, renset / fiskeolje, rik på omega-3-syrer - infusjonsvæske, emulsjon - 60 g/ l / 60 g/ l / 50 g/ l / 30 g/ l